Volume 59, Issue 3 p. E22
Letter to the Editor

Cost of illness, cost of immunoglobulin therapy and their determinants in chronic inflammatory demyelinating polyneuropathy

Yusuf A. Rajabally MD, FRCP

Yusuf A. Rajabally MD, FRCP

School of Life and Health Sciences, Aston Brain Centre, Aston University, Birmingham, UK

Regional Neuromuscular Clinic, Queen Elizabeth Hospital, University Hospitals of Birmingham, Birmingham, UK

Search for more papers by this author
First published: 08 January 2019
Citations: 1

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me